Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

    Vous êtes ici :  
  1. Accueil
  2. Blog With Right Sidebar

More Non-Smokers Are Being Diagnosed With Lung Cancer

New research has found that the number of non-smokers being diagnosed with non-small cell lung cancer has increased. The study, which will be presented today at the European Respiratory Society's Annual Congress in Vienna, also discovered that the the number of women being diagnosed with this type of cancer is increasing as well... (Source: Health News from Medical News Today)

Horizon scanning: Analyses of ongoing RECAP study of pirfenidone (EsbrietT) for idiopathic pulmonary fibrosis presented at conference

Source: BioSpace Area: News Biospace has reported on new analyses of data from the RECAP extension study of pirfenidone (EsbrietT) which were presented at the 2012 Annual Congress of the European Respiratory Society (ERS) in Vienna.   The RECAP study (n=603) is an ongoing open-label extension study evaluating the long-term administration of pirfenidone in patients who received placebo in the Phase III CAPACITY program (studies 004 and 006) which evaluated pirfenidone in idiopathic pulmonary fibrosis (IPF) patients with mild to moderate impairment in lung function (n=626).   This new analyses focused on the patients who at the time of entry into RECAP had baseline FVC and DLco values that would have met the original eligibility criteria for CAPACITY. Of the 274 newly tre...

Study Sheds Light On Lung Cancers That Are Undetected By Radiograph

New research has revealed why some lung cancers are undetected by radiograph and helped to identify the type of people who may be at risk of this form of the disease. The findings was presented on Monday (3 September 2012) at the European Respiratory Society's Annual Congress in Vienna. There has been no significant reduction in lung cancer mortality rates in recent years. Chest radiographs can be used to screen for lung cancer... (Source: Health News from Medical News Today)

Asthma Treatment Tiotropium Receives Positive Results

First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated with ICS/LABA Published in the New England Journal of Medicine. Data simultaneously presented at the 2012 European Respiratory Society Congress Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma™ program... (Source: Health News from Medical News Today)

Asthma Treatment With Omalizumab (Xolair®), New Data Shows Benefits

New data analyses presented at the European Respiratory Society (ERS) Annual Congress in Vienna show that long-term treatment with omalizumab (Xolair®) significantly improves a range of outcomes for people with severe persistent allergic asthma, a chronic condition affecting an estimated 14,315 people in the UK4. Asthma can be a devastating condition, causing an average of three deaths in the UK every day, 90% of which are preventable with optimal management5... (Source: Health News from Medical News Today)

Search

Search